Skip to content
Recall Observatory FDA recall evidence

Drug product

Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-200-10

D-0443-2024

March 25, 2024

Class III

Product summary

Firm
Novitium Pharma LLC
Event
Event 94255
Status
Terminated
Classification
Class III
Quantity
1,003 bottles
Official record key
drug-enforcement:D-0443-2024

Official wording

Reason: Failed Impurities/Degradation Specifications

Code information: Lot M23011A; Exp. 12/2024

Distribution pattern: U.S. Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications